From hypertension control to global cardiovascular risk management: An educational intervention in a cluster-randomised controlled trial Clinical presentation, diagnosis, and management

BMC Family Practice

Volumn 16, Issue 1, 2015, Pages

  Mortsiefer, Achim ^a   Meysen, Tobias ^a   Schumacher, Martin ^a   Abholz, Heinz Harald ^a   Wegscheider, Karl ^b   In Der Schmitten, Jürgen ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cardiovascular diseases; Educational intervention; Hypertension; Prevention and control; Primary care

Indexed keywords

AGED; ATTITUDE TO HEALTH; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE MANAGEMENT; FEMALE; GENERAL PRACTICE; GERMANY; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; FEMALE; GENERAL PRACTICE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PREVENTIVE HEALTH SERVICES; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR;

EID: 85018134457     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-015-0274-1     Document Type: Article

References (31)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice, third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24(17):1601-10.
2. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365(9457):434-41.
3. Alderman MH. Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med. 1993;119(4):329-35.
4. Volpe M, Alderman MH, Furberg CD, Jackson R, Kostis JB, Laragh JH, et al. Beyond hypertension toward guidelines for cardiovascular risk reduction. Am J Hypertens. 2004;17(11 Pt 1):1068-74.
5. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004;328(7440):634-40.
6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007;25(9):1751-62.
7. Deutsche Hochdruckliga e.V. DHL® - Deutsche Hypertonie Gesellschaft. Leitlinien zu Diagnostik und Behandlung der arteriellen Hypertonie. Nieren- und Hochdruckkrankheiten. 2005;34:481-9.
8. Tobe SW, Stone JA, Brouwers M, Bhattacharyya O, Walker KM, Dawes M, et al. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. CMAJ. 2011;183(15):E1135-50.
9. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43(1):10-7.
10. Fahey TP, Peters TJ. A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients. Br J Gen Pract. 1996;46(412):655-9.
11. Torley D, Zwar N, Comino EJ, Harris M. GPs' views of absolute cardiovascular risk and its role in primary prevention. Aust Fam Physician. 2005;34(6):503-4. 507.
12. Geller JC, Cassens S, Brosz M, Keil U, Bernarding J, Kropf S, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart J. 2007;28(24):3051-8.
13. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043-50.
14. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183(9):1007-13.
15. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010;3:CD005182.
16. Krones T, Keller H, Sonnichsen A, Sadowski EM, Baum E, Wegscheider K, et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Ann Fam Med. 2008;6(3):218-27.
17. Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med. 2003;18(12):1039-52.
18. Christiaens T. Cardiovascular risk tables. BMJ. 2008;336(7659):1445-6.
19. Shillinglaw B, Viera AJ, Edwards T, Simpson R, Sheridan SL. Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians. BMC Health Serv Res. 2012;12:20.
20. van Steenkiste B, Grol R, van der Weijden T. Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases. Vasc Health Risk Manag. 2008;4(3):535-45.
21. van Steenkiste B, van der Weijden T, Stoffers HE, Kester AD, Timmermans DR, Grol R. Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. Eur J Cardiovasc Prev Rehabil. 2007;14(1):44-50.
22. Mortsiefer A, Meysen T, Schumacher M, Lintges C, Stamer M, Schmacke N, et al. CRISTOPH - a cluster-randomised intervention study to optimise the treatment of patients with hypertension in General Practice. BMC Fam Pract. 2008;9:33.
23. In der Schmitten J, Wegscheider K, Abholz HH, Mortsiefer A. Risk-adjusted versus overall blood pressure control rate for identifying the need for intensified cardiovascular risk reduction: lessons from a cross-sectional study. Eur J Prev Cardiol. 2013;20(6):972-9.
24. Grimshaw J, Eccles M, Tetroe J. Implementing clinical guidelines: current evidence and future implications. J Contin Educ Heal Prof. 2004;24 Suppl 1:S31-7.
25. O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007;4:CD000409.
26. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;2:CD000172.
27. Campbell MK, Piaggio G, Elbourne DR, Altman DG, CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.
28. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72.
29. Koelewijn-van Loon MS, van der Weijden T, van Steenkiste B, Ronda G, Winkens B, Severens JL, et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. CMAJ. 2009;181(12):E267-74.
30. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):iii-iv. 1-72.
31. Stamer M. Der Umgang mit Risiken Hausärztliche Versorgung zwischen Tradition und Moderne. Weinheim, München; 2011.